Bladder Carcinoma in Situ

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-16
Clinical Trial Update: Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) [Phase 3]
A Phase 3 clinical trial of ONCOFID-P-B (paclitaxel-hyaluronic acid) for bladder carcinoma in situ is currently recruiting.